Kyowa Kirin Co (STU:KY4) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:KY4 Kyowa Kirin Co Ltd STU:KY4
87 GF Score
Price €12.30
GF Value €15.14
Valuation Modestly Undervalued
View Full Analysis

What is Kyowa Kirin Co Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

STU:KY4
87GF Score
Kyowa Kirin Co Ltd STU:KY4
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Kyowa Kirin Co (STU:KY4) Overvalued in 2026?

Based on GuruFocus' analysis, Kyowa Kirin Co stock appears to be undervalued. The current stock price of €12.30 is trading 18.8% below its estimated GF Value™ of €15.14. GuruFocus considers Kyowa Kirin Co to be Modestly Undervalued.

Key valuation signals for STU:KY4:

  • Dividends Received:
  • GF Value™: €15.14 vs. price of €12.30 (18.8% below fair value)
  • GF Score™: 87/100

No single metric tells the full story. See the STU:KY4 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Kyowa Kirin Co Business Description

Address 1-9-2 Otemachi, Chiyoda-ku, Chiyoda-ku, Tokyo, JPN, 100-0004
Kyowa Kirin Co Ltd is engaged in research, development, manufacturing, sales, import and export of prescription pharmaceuticals. Its products include KHK4083/AMG 451, rocatinlimab; ziftomenib; OTL-203 KK8398, infigratinib; KHK4951, tivozanib; OTL-201; KK4277; KK2260; KK2269; KK2845; and KK8123.
87GF Score

Get the complete analysis for STU:KY4

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€12.30
Price
€15.14
GF Value